34 results
POS AM
QNRX
Quoin Pharmaceuticals Ltd
29 Mar 24
Prospectus update (post-effective amendment)
4:11pm
a variety of medical issues including regular, severe infections, skin cancer, chronic pruritis, asthma, and allergies among others.
Newborns with NS have … is a chronic disease and does not spontaneously resolve, we believe there is an opportunity for the product, should it be approved, for long-term
424B3
QNRX
Quoin Pharmaceuticals Ltd
8 Mar 24
Prospectus supplement
4:06pm
infections, as well as a pronounced predisposition to allergies, asthma, and eczema. Patients also often suffer from severe dehydration, chronic skin
424B3
QNRX
Quoin Pharmaceuticals Ltd
8 Mar 24
Prospectus supplement
4:04pm
, and eczema. Patients also often suffer from severe dehydration, chronic skin inflammation and stunted growth.
Currently, there is no cure for Netherton
8-K
EX-99.1
QNRX
Quoin Pharmaceuticals Ltd
8 Mar 24
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
4:01pm
also often suffer from severe dehydration, chronic skin inflammation and stunted growth.
Currently, there is no cure for Netherton Syndrome, nor
424B4
dx1f2snr06egkzz 09
6 Mar 24
Prospectus supplement with pricing info
5:07pm
424B3
1qhip6hs
4 Mar 24
Prospectus supplement
5:27pm
8-K
EX-99.1
97h5x 09t0pfy
18 Dec 23
Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
5:29pm
424B4
s42orj 7l43g9o2w9z1
8 Aug 22
Prospectus supplement with pricing info
5:49pm
F-1/A
nmvmvhhb3
4 Aug 22
Registration statement (foreign) (amended)
11:44am
F-1
tat53
2 Aug 22
Registration statement (foreign)
9:49pm
424B3
3v8jeupn0
25 Apr 22
Prospectus supplement
6:40pm
F-1
bo7vxr1123 zy0ma
15 Apr 22
Registration statement (foreign)
12:00am
6-K
EX-99.2
umt bu65bkc
13 Aug 21
Current report (foreign)
5:21pm
F-4/A
e5se64vz
10 Aug 21
Registration of securities (foreign) (amended)
3:22pm
F-4/A
t91y1r
5 Aug 21
Registration of securities (foreign) (amended)
9:24pm
F-4/A
q6jpo 9qp
16 Jul 21
Registration of securities (foreign) (amended)
4:09pm